Mapping global policy discourse on antimicrobial resistance

BMJ Global Health

Volumn 2, Issue 2, 2017, Pages

  Wernli, Didier ^a   Jørgensen, Peter S ^b,c   Morel, Chantal M ^d,e   Carroll, Scott ^f,g   Harbarth, Stephan ^d   Levrat, Nicolas ^a   Pittet, Didier ^d  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b ROYAL SWEDISH ACADEMY OF SCIENCES   (Sweden)

^c STOCKHOLM UNIVERSITY   (Sweden)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^e LONDON SCHOOL OF ECONOMICS   (United Kingdom)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g Institute for Contemporary Evolution   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85029307697     PISSN: None     EISSN: 20597908     Source Type: Journal    
DOI: 10.1136/bmjgh-2017-000378     Document Type: Article

References (82)

1. The review on antimicrobial resistance. Tackling drug-resistant infections globally - Final Report and Recommendations 2016 https://amr-review.org/sites/default/files/160518_Final%20paper_with%20cover.pdf (accessed 12 June 2017).
2. World Health Organization. Global Action Plan on Antimicrobial Resistance. Geneva: World Health Organization 2015 http://www.who.int/antimicrobial-resistance/publications/global-action-plan/en/(accessed 18 March 2017).
3. OIE. The OIE Strategy on Antimicrobial Resistance and the prudent use of antimicrobials. Paris: OIE 2016 http://www.oie.int/fileadmin/Home/eng/Media_Center/docs/pdf/PortailAMR/EN_OIE-AMRstrategy.pdf (accessed 18 March 2017).
4. FAO. The FAO Action Plan on antimicrobial resistance 2016-2020. Roma: FAO 2016 http://www.fao.org/3/a-i5996e.pdf (accessed 18 March 2017).
5. United Nations. Political declaration of the high-level meeting of the General Assembly on antimicrobial resistance. New York: United Nations 2016 http://www.un.org/pga/71/wp-content/uploads/sites/40/2016/09/DGACM_GAEAD_ESCAB-AMR-Draft-Political-Declaration-1616108E.pdf (accessed 18 October 2016).
6. ReAct. AMR Stakeholder mapping. Uppsala:. 2016 https://www.reactgroup.org/uploads/Stakeholder%20Analysis_ReActForWHO. pdf (accessed 18 March 2017).
7. Lang T, Rayner G. Overcoming policy cacophony on obesity: an ecological public health framework for policymakers. Obes Rev 2007;8 Suppl 1(Suppl 1):165–81.
8. McInnes C, Lee K. Global health and international relations. Cambridge: Polity, 2012.
9. Shiffman J. A social explanation for the rise and fall of global health issues. Bull World Health Organ 2009;87:608–13.
10. Stuckler D, McKee M. Five metaphors about global-health policy. Lancet 2008;372:95–7.
11. McInnes C, Roemer-Mahler A. Competition and Cooperation in Global Health Governance: the Impact of Multiple Framings. In: Freeman M, Hawkes S, Bennett B, eds. Law and Global Health: current Legal Issues. 16, 2014. Volume Oxford Scholarship Online.
12. Gopinathan U, Watts N, Hougendobler D, et al. Conceptual and institutional gaps: understanding how the WHO can become a more effective cross-sectoral collaborator. Global Health 2015;11:46.
13. Mason Meier B. An Agenda for Normative Policy Analysis in the Study of Global Health Governance. In: Freeman M, Hawkes S, Bennett B, eds. Law and Global Health: current Legal Issues. 16, 2014. Volume Oxford Scholarship Online.
14. McInnes C, Kamradt-Scott A, Lee K, et al. Framing global health: the governance challenge. Glob Public Health 2012;7 Suppl 2(Suppl 2):S83–S94.
15. Kamradt-Scott A. Evidence-based medicine and the governance of pandemic influenza. Glob Public Health 2012;7 Suppl 2(Suppl 2):S111–S126.
16. Labonté R, Gagnon ML. Framing health and foreign policy: lessons for global health diplomacy. Global Health 2010;6:14.
17. Kamradt-Scott A, McInnes C. The securitisation of pandemic influenza: framing, security and public policy. Glob Public Health 2012;7 Suppl 2(Suppl 2):S95–S110.
18. Labonté R. Global health in public policy: finding the right frame? Crit Public Health 2008;18:467–82.
19. Reubi D. Making a human right to tobacco control: expert and advocacy networks, framing and the right to health. Glob Public Health 2012;7 Suppl 2(Suppl 2):S176–S190.
20. van Dijk TA. Principles of critical discourse analysis. Discourse & Society 1993;4:249–83.
21. Wodak R, Meyer M. Methods for critical discourse analysis. 2nd ed: Thousand Oaks: Sage, 2009.
22. Clark J. Medicalization of global health 1: has the global health agenda become too medicalized? Glob Health Action 2014;7:23998.
23. Podolsky SH. The antibiotic era: reform, resistance, and the pursuit of a rational therapeutics. Baltimore: Johns Hopkins University Press, 2015.
24. Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: guidelines by the infectious diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis 2016;62:e51–e77.
25. Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis 2006;42 Suppl 2(Suppl 2):S82–S89.
26. Cosgrove SE, Sakoulas G, Perencevich EN, et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003;36:53–9.
27. Okeke IN, Laxminarayan R, Bhutta ZA, et al. Antimicrobial resistance in developing countries. part I: recent trends and current status. Lancet Infect Dis 2005;5:481–93.
28. Okeke IN, Klugman KP, Bhutta ZA, et al. Antimicrobial resistance in developing countries. Part II: strategies for containment. Lancet Infect Dis 2005;5:568–80.
29. Mendelson M, Røttingen JA, Gopinathan U, et al. Maximising access to achieve appropriate human antimicrobial use in low-income and middle-income countries. Lancet 2016;387:188–98.
30. Kelesidis T, Kelesidis I, Rafailidis PI, et al. Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence. J Antimicrob Chemother 2007;60:214–36.
31. Laxminarayan R, Matsoso P, Pant S, et al. Access to effective antimicrobials: a worldwide challenge. Lancet 2016;387:168–75.
32. World Health Organization. Anti-tuberculosis drug resistance in the world: the WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance 1994 -. Geneva: WHO, 1997.
33. Ashley EA, Dhorda M, Fairhurst RM, et al. Spread of artemisinin resistance in plasmodium falciparum malaria. N Engl J Med 2014;371:411–23.
34. Brandt AM. How AIDS invented global health. N Engl J Med 2013;368:2149–52.
35. Jasovský D, Littmann J, Zorzet A, et al. Antimicrobial resistance-a threat to the world's sustainable development. Ups J Med Sci 2016;121:159–64.
36. United Nations General Assembly. Transforming our world: the 2030 agenda for sustainable development. New York: United Nations 2015 http://www.un.org/ga/search/view_doc.asp?symbol=A/RES/70/1&Lang=E (accessed 18 March 2017).
37. Hollis A, Maybarduk P. Antibiotic resistance is a tragedy of the Commons that necessitates global cooperation. J Law Med Ethics 2015;43 Suppl 3:33–7.
38. Okeke I. The tragedy of antimicrobial resistance: achieving a recognition of necessity. Current science 2009;97:1564.
39. Laxminarayan R. Antibiotic effectiveness: balancing conservation against innovation. Science 2014;345:1299–301.
40. Jørgensen PS, Wernli D, Carroll SP, et al. Use antimicrobials wisely. Nature 2016;537:159–61.
41. Access to Medicine Foundation. Access to Medicine Index, 2016.
42. Kotwani A, Holloway K. Access to antibiotics in New Delhi, India: implications for antibiotic policy. J Pharm Policy Pract 2013;6:6.
43. Aminov RI. A brief history of the antibiotic era: lessons learned and challenges for the future. Front Microbiol 2010;1:134.
44. Podolsky SH, Bud R, Gradmann C, et al. History teaches Us that confronting antibiotic resistance requires Stronger Global Collective Action. J Law Med Ethics 2015;43 Suppl 3:27–32.
45. Bettiol E, Harbarth S. Development of new antibiotics: taking off finally? Swiss Med Wkly 2015;145:w14167.
46. Cooper MA, Shlaes D. Fix the antibiotics pipeline. Nature 2011;472:32.
47. Renwick MJ, Brogan DM, Mossialos E. A systematic review and critical assessment of incentive strategies for discovery and development of novel antibiotics. J Antibiot 2016;69.
48. Heymann DL, Chen L, Takemi K, et al. Global health security: the wider lessons from the west african ebola virus disease epidemic. Lancet 2015;385:1884–901.
49. Rushton S. Global Health Security: security for whom? security from what? Polit Stud 2011;59:779–96.
50. Flahault A, Wernli D, Zylberman P, et al. From global health security to global health solidarity, security and sustainability. Bull World Health Organ 2016;94:863.
51. Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010;10:597–602.
52. Davies SE. Securitizing infectious disease. International Affairs 2008;84:295–313.
53. Aldis W. Health security as a public health concept: a critical analysis. Health Policy Plan 2008;23:369–75.
54. Chan M. Address to the Sixty-ninth World Health Assembly. Geneva: World Health Organization, 2016. http://www.who.int/dg/speeches/2016/wha-69/en/. (accessed 4 April 2017).
55. Wernli D, Haustein T, Conly J, et al. A call for action: the application of the International Health Regulations to the global threat of antimicrobial resistance. PLoS Med 2011;8:e1001022.
56. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States. 2013: Centres for Disease Control and Prevention, US Department of Health and Human Services 2013.
57. Global Health Security Agenda. Antimicrobial Resistance Action Package. non dated https://www.ghsagenda.org/packages/p1-antimicrobial-resistance (accessed 18 March 2017).
58. Berglund B. Environmental dissemination of antibiotic resistance genes and correlation to anthropogenic contamination with antibiotics. Infect Ecol Epidemiol 2015;5:28564.
59. World Health Organization. Antimicrobial resistance: a threat to global health security. rational use of medicines by prescribers and patients. Geneva: World Health Organization, 2005.
60. World Health Organization. The world health report 2007: a safer future. global public health security in the 21st century. Geneva: World Health Organization 2007.
61. American Veterinary Medical Association. One health: a new professional imperative. One Health Initiative Task Force Final Report. 2008 https://www.avma.org/KB/Resources/Reports/Documents/onehealth_final.pdf (accessed 3 June 2017).
62. Liu YY, Wang Y, Walsh TR, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 2016;16.
63. Glad T, Bernhardsen P, Nielsen KM, et al. Bacterial diversity in faeces from polar bear (Ursus maritimus) in Arctic Svalbard. BMC Microbiol 2010;10:10.
64. Berendonk TU, Manaia CM, Merlin C, et al. Tackling antibiotic resistance: the environmental framework. Nat Rev Microbiol 2015;13:310–7.
65. Martínez JL. Antibiotics and antibiotic resistance genes in natural environments. Science 2008;321:365–7.
66. Zinsstag J, Schelling E, Waltner-Toews D, et al. From "one medicine" to "one health" and systemic approaches to health and well-being. Prev Vet Med 2011;101:148–56.
67. Van Boeckel TP, Brower C, Gilbert M, et al. Global trends in antimicrobial use in food animals. Proc Natl Acad Sci U S A 2015;112:5649–54.
68. Robinson TP, Bu DP, Carrique-Mas J, et al. Antibiotic resistance is the quintessential one Health issue. Trans R Soc Trop Med Hyg 2016;110:377–80.
69. World Health Organization, Food and Agriculture Organization of the United Nations, World Organisation for Animal Health. The FAO-OIE-WHO collaboration. sharing responsibilities and coordinating global activities to address health risks at the animal-human-ecosystems interfaces. A tripartite concept note 2010 http://www.who.int/foodsafety/zoonoses/final_concept_note_Hanoi.pdf?ua=1 (accessed 18 March 2017).
70. Castanon JI. History of the use of antibiotic as growth promoters in european poultry feeds. Poult Sci 2007;86:2466–71.
71. The Federal Council. Strategy on Antibiotic Resistance Switzerland, 2015. https://www.bundespublikationen.admin.ch/cshop_mimes_bbl/8C/8CDCD4590EE41EE6A9FA4BAB41DE6BB3.pdf. (accessed 18 March 2017).
72. Wernli D, Darbellay F. Interdisciplinarity and the 21st century University. Brussels: League of European Research Universities, 2016.
73. Kickbusch I. Politics or technocracy - What next for Global Health? comment on "Navigating Between Stealth Advocacy and Unconscious Dogmatism: The Challenge of Researching the Norms, Politics and Power of Global Health". Int J Health Policy Manag 2015;5:201–4.
74. Saez C. World Health Assembly adopts Resolution to fight Sepsis; Antimicrobial Resistance Major threat. Intellectual Property Watch 2017 https://www.ip-watch.org/2017/05/26/world-health-assemblyadopts-resolution-fight-sepsis-antimicrobial-resistance-major-threat/(accessed 3 June 2017).
75. Murphy H, Kellow A. Forum Shopping in Global Governance: understanding States, Business and NGOs in multiple arenas. Glob Policy 2013;4:139–49.
76. Hoffman SJ, Outterson K. INTRODUCTION: what will it take to address the global threat of Antibiotic Resistance? J Law Med Ethics 2015;43 Suppl 3:6–11.
77. Mendelson M, Dar OA, Hoffman SJ, et al. A global antimicrobial Conservation Fund for low- and Middle-Income Countries. Int J Infect Dis 2016;51:70–2.
78. Human Right Council. Access to medicines in the context of the right of everyone to the enjoyment of the highest attainable standard of physical and mental health. Geneva: Human Right Council, 2016.
79. Abbott F, . et alTrade in medicines. In: Smith R, Blouin C, Mirza Z, Drager N, Beyer P, . eds. Trade and health: building a national strategy: world Health Organization, 2015.
80. Outterson K, Gopinathan U, Clift C, et al. Delinking Investment in Antibiotic Research and Development from sales revenues: the challenges of transforming a Promising Idea into reality. PLoS Med 2016;13:e1002043.
81. Commission of the European Communities. Ban on antibiotics as growth promoters in animal feed enters into effect (IP/05/1687) 2005.http://europa.eu/rapid/pressReleasesAction.do?reference=IP/05/1687&type=HTML&aged=0&language=EN&guiLanguage=en (accessed 20 November 2010).
82. Whitmee S, Haines A, Beyrer C, et al. Safeguarding human health in the Anthropocene epoch: report of the Rockefeller Foundation-Lancet Commission on planetary health. Lancet 2015;386:1973–2028.